JB

Jeffrey B. Kindler

North America, New York, United States, New York

Description

Jeff Kindler is the CEO of Centrexion Therapeutics. He brings more than three decades of business experience and has held leadership posit...

Investor Profile

Jeffrey B. Kindler has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Seed (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Artificial Intelligence (Ai)
  • Biotechnology
  • Electronics
  • Hardware
  • Robotics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Jeffrey B. Kindler frequently co-invest with?

HAX
North America, California, United States, San Francisco
Co-Investments: 1
TGM ventures
North America, California, United States, Santa Monica
Co-Investments: 1
SOSV
North America, New Jersey, United States, Princeton
Co-Investments: 1
MBX Capital
North America, New York, United States, New York
Co-Investments: 1
Y Combinator
North America, California, United States, Mountain View
Co-Investments: 1
SP Investment Fund
North America, California, United States, Santa Monica
Co-Investments: 1
Fifty Years
North America, California, United States, San Francisco
Co-Investments: 1
Lerer Hippeau
North America, New York, United States, New York
Co-Investments: 1
Khosla Ventures
North America, California, United States, Menlo Park
Co-Investments: 1

What are some of recent deals done by Jeffrey B. Kindler?

Opentrons

Brooklyn, New York, United States

Opentrons is a life science company that develops pipetting robot technology designed to automate experiments.

Artificial Intelligence (AI)BiotechnologyElectronicsHardwareRobotics
SeedMar 27, 2018
Amount Raised: $10,000,000